Mode
Text Size
Log in / Sign up
N/A N=73 Randomized Double-blind Treatment

Clinical Trial of Peripheral Prism Glasses for Hemianopia

Homonymous Hemianopia

Enrolled (actual)
73
Serious AEs
0.0%
Results posted
Sep 2013
Primary outcome: Primary: Overall Proportion Saying "Yes" to Real Prism Glasses — 39; 22 participants — p== 0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
High power (57 prism diopter) peripheral prism glasses (Device); Low power sham peripheral prism glasses (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Alexandra Bowers
Primary completion
Jul 2009

Outcome Measures

OutcomeResultp-value
PRIMARY
Overall Proportion Saying "Yes" to Real Prism Glasses
39; 22 = 0.001 sig
SECONDARY
Mobility Change Score (All Participants Who Completed Crossover)
1.9; 1.3 = 0.09
SECONDARY
Mobility Change Score (Only Participants Who Continued Prism Wear in the Long Term)
3.0; 1.1 = 0.002 sig
SECONDARY
Mobility Change Score (Only Participants Who Discontinued Prism Wear in the Long Term)
1.1; 1.6 = 0.21

Summary

The purpose of this study is to evaluate the functional utility for general mobility (walking) of new high power permanent peripheral prism glasses, which provide visual field expansion device for patients with homonymous hemianopia (the complete loss of half the field of vision on the same side in both eyes). The efficacy of real peripheral prism glasses will be assessed relative to sham peripheral prism glasses.

Eligibility Criteria

Inclusion Criteria

  • At least 18 years of age.
  • Sighted in both eyes, with monocular visual acuity (best corrected vision), of at least 20/50 in each eye.
  • Complete homonymous hemianopia of more than 3 months duration
  • Refractive error within the -5 dioptre to +5 dioptre range
  • No significant cognitive impairment
  • No history of wearing the Peli system of peripheral prisms for hemianopic field expansion (patients who have worn another type of prismatic correction for hemianopia such as yoked prisms or the Gottlieb VAS system can participate in the study)
  • No physical or mental disabilities, including cognitive dysfunction, balance problems or other deficits that could impair ability to walk or use the peripheral prism spectacles.
  • Able to walk (using a cane or walker is OK) or control the movements of their own wheelchair.
  • In sufficiently good health to attend four in-office visits.

Exclusion Criteria

  • Diagnosis of dementia
  • Diagnosis of visual neglect
  • History of seizures in the last 6 months
  • Incomplete hemianopia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00494676). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search